EE200100187A - Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga - Google Patents

Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga

Info

Publication number: EE200100187A
Authority: EE; Estonia
Prior art keywords: acetyldinaline; capecitabine; gemcitabine; cisplatin; combination
Prior art date: 1998-09-25

Application number

EEP200100187A

Other languages

English (en)

Estonian (et)

Inventor

Richard Grove William

Daniel Klohs Wayne

Lynn Merriman Ronald

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-07-08

Publication date

2002-08-15

1999-07-08 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2002-08-15 Publication of EE200100187A publication Critical patent/EE200100187A/xx

Links

GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 title 1
GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
229960004117 capecitabine Drugs 0.000 title 1
238000002512 chemotherapy Methods 0.000 title 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title 1
229960004316 cisplatin Drugs 0.000 title 1
229960005277 gemcitabine Drugs 0.000 title 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 title 1
VAZAPHZUAVEOMC-UHFFFAOYSA-N tacedinaline Chemical compound C1=CC(NC(=O)C)=CC=C1C(=O)NC1=CC=CC=C1N VAZAPHZUAVEOMC-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EEP200100187A 1998-09-25 1999-07-08 Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga EE200100187A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10180998P	1998-09-25	1998-09-25
PCT/US1999/015386 WO2000018393A1 (en)	1998-09-25	1999-07-08	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin

Publications (1)

Publication Number	Publication Date
EE200100187A true EE200100187A (et)	2002-08-15

Family

ID=22286531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100187A EE200100187A (et)	1998-09-25	1999-07-08	Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga

Country Status (34)

Country	Link
US (3)	US6469058B1 (cs)
EP (1)	EP1115391B1 (cs)
JP (1)	JP2002525320A (cs)
KR (1)	KR20010075348A (cs)
CN (1)	CN1319009A (cs)
AP (1)	AP2001002109A0 (cs)
AT (1)	ATE225655T1 (cs)
AU (1)	AU762079B2 (cs)
BG (1)	BG105470A (cs)
BR (1)	BR9913952A (cs)
CA (1)	CA2342981A1 (cs)
CZ (1)	CZ2001905A3 (cs)
DE (1)	DE69903458T2 (cs)
DK (1)	DK1115391T3 (cs)
EA (1)	EA200100369A1 (cs)
EE (1)	EE200100187A (cs)
ES (1)	ES2185378T3 (cs)
GE (1)	GEP20043199B (cs)
HK (1)	HK1040190A1 (cs)
HR (1)	HRP20010225B1 (cs)
HU (1)	HUP0103640A3 (cs)
ID (1)	ID30046A (cs)
IL (1)	IL141951A0 (cs)
IS (1)	IS5888A (cs)
NO (1)	NO20011493L (cs)
NZ (1)	NZ510504A (cs)
OA (1)	OA11659A (cs)
PL (1)	PL348673A1 (cs)
PT (1)	PT1115391E (cs)
SK (1)	SK3602001A3 (cs)
TR (1)	TR200100859T2 (cs)
WO (1)	WO2000018393A1 (cs)
YU (1)	YU22401A (cs)
ZA (1)	ZA200102233B (cs)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2342981A1 (en) *	1998-09-25	2000-04-06	Warner-Lambert Company	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
CZ20022216A3 (cs) *	2001-07-02	2003-05-14	Warner-Lambert Company	Kombinační chemoterapie
US20080075762A1 (en) *	2001-10-03	2008-03-27	Paul Tardi	Compositions for delivery of drug combinations
CA2383259A1 (en)	2002-04-23	2003-10-23	Celator Technologies Inc.	Synergistic compositions
US7850990B2 (en) *	2001-10-03	2010-12-14	Celator Pharmaceuticals, Inc.	Compositions for delivery of drug combinations
US7456219B2 (en)	2002-03-04	2008-11-25	Merck Hdac Research, Llc	Polymorphs of suberoylanilide hydroxamic acid
US20040132825A1 (en) *	2002-03-04	2004-07-08	Bacopoulos Nicholas G.	Methods of treating cancer with HDAC inhibitors
WO2003075839A2 (en) *	2002-03-04	2003-09-18	Aton Pharma, Inc.	Methods of inducing terminal differentiation
CN100566711C (zh) *	2002-04-15	2009-12-09	斯隆-凯特林癌症研究院	治疗癌症的化合物及其用途
US20070032422A1 (en)	2002-10-24	2007-02-08	Spectrum Pharmaceuticals, Inc.	Methods, compositions and articles of manufacture for contributing to the treatment of cancers
US8026216B2 (en)	2002-10-24	2011-09-27	Spectrum Pharmaceuticals, Inc.	Methods and compositions for contributing to the treatment of cancers
GB0226434D0 (en) *	2002-11-13	2002-12-18	Astrazeneca Ab	Combination product
JP2006508974A (ja) *	2002-11-15	2006-03-16	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	癌を治療するためのｍｅｋ阻害剤およびカペシタビン（ｃａｐｅｃｉｔａｂｉｎｅ）を含む併用化学療法
RU2240117C1 (ru) *	2003-04-01	2004-11-20	Алтайский государственный медицинский университет	Способ лечения больных с местнораспространенными формами плоскоклеточного рака с локализацией в области слизистой оболочки полости рта и ротового отдела глотки
EP1643971A2 (en) *	2003-05-22	2006-04-12	Neopharm, Inc.	Liposomal formulations comprising a combination of two or more active agents
PE20050206A1 (es) *	2003-05-26	2005-03-26	Schering Ag	Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
CN100431606C (zh) *	2004-11-22	2008-11-12	山东蓝金生物工程有限公司	一种抗癌药物组合物
US7957507B2 (en)	2005-02-28	2011-06-07	Cadman Patrick F	Method and apparatus for modulating a radiation beam
CN100443081C (zh) *	2005-04-05	2008-12-17	吴一心	木犀草素与一种铂类化疗药物联合用于制备抗肿瘤的药物
US8232535B2 (en)	2005-05-10	2012-07-31	Tomotherapy Incorporated	System and method of treating a patient with radiation therapy
AU2006272730A1 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method of and system for predicting dose delivery
US8229068B2 (en)	2005-07-22	2012-07-24	Tomotherapy Incorporated	System and method of detecting a breathing phase of a patient receiving radiation therapy
WO2007014105A2 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method and system for adapting a radiation therapy treatment plan based on a biological model
CA2616306A1 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method and system for processing data relating to a radiation therapy treatment plan
EP1907064B1 (en)	2005-07-22	2011-06-08	TomoTherapy, Inc.	Method of defining a region of interest using a dose volume histogram
US8767917B2 (en)	2005-07-22	2014-07-01	Tomotherapy Incorpoated	System and method of delivering radiation therapy to a moving region of interest
EP1907968A4 (en) *	2005-07-22	2009-10-21	Tomotherapy Inc	METHOD AND SYSTEM FOR EVALUATING QUALITY ASSURANCE CRITERIA FOR A TREATMENT ADMINISTRATION PROGRAM
EP1906827A4 (en)	2005-07-22	2009-10-21	Tomotherapy Inc	SYSTEM AND METHOD FOR EVALUATING A DOSE ADMINISTERED BY A RADIATION THERAPY SYSTEM
KR20080039926A (ko)	2005-07-22	2008-05-07	토모테라피 인코포레이티드	전달된 방사선량의 평가 방법 및 시스템
CN101529442A (zh)	2005-07-22	2009-09-09	断层放疗公司	在形变图上放置约束的方法及实现该方法的系统
US8442287B2 (en)	2005-07-22	2013-05-14	Tomotherapy Incorporated	Method and system for evaluating quality assurance criteria in delivery of a treatment plan
CN101267767A (zh)	2005-07-23	2008-09-17	断层放疗公司	使用机架和治疗床的协同运动的放射疗法成像和实施
EP2059254B1 (en)	2006-08-31	2015-04-08	Spectrum Pharmaceuticals, Inc.	Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists
USRE45471E1 (en) *	2008-01-28	2015-04-14	Nanocarrier Co., Ltd.	Pharmaceutical composition or combination drug
FR2937867B1 (fr) *	2008-11-03	2011-03-04	Biorebus	Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
JP5687687B2 (ja)	2009-04-06	2015-03-18	大塚製薬株式会社	癌を治療するための（２’−デオキシ−リボフラノシル）−１，３，４，７−テトラヒドロ−（１，３）ジアゼピン−２−オン誘導体
WO2012003413A1 (en) *	2010-06-30	2012-01-05	The Broad Institute, Inc.	Novel solid forms of tacedinaline
US8691875B2 (en)	2011-07-01	2014-04-08	Broad Institute, Inc.	Solid forms of tacedinaline
US9308235B2 (en)	2012-05-09	2016-04-12	Spectrum Pharmaceuticals, Inc.	Treatment of primary and metastatic carcinoma
EP2711008A1 (en)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	N6,N6-dimethyladenosine for use in treating or preventing primary and metastatic breast cancer
EP2711007A1 (en)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	4-Aminopyrazolo[3,4-d]pyrimidine for use in treating or preventing primary and metastatic breast and prostate cancer
EP2711009A1 (en)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	Compounds for use in treating or preventing primary and metastatic breast and prostate cancer
JP6412020B2 (ja)	2013-02-26	2018-10-24	アキュレイインコーポレイテッド	電磁作動式のマルチリーフコリメーター
US10189797B2 (en)	2015-12-30	2019-01-29	Duke University	Chemical modulators of immune checkpoints and therapeutic use
WO2020028392A1 (en)	2018-07-30	2020-02-06	Duke University	Niclosamide analogues and therapeutic use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5562925A (en) *	1970-04-20	1996-10-08	Research Corporation Tech. Inc.	Anti-tumor method
NZ219974A (en) *	1986-04-22	1989-08-29	Goedecke Ag	N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
AU671491B2 (en) *	1992-12-18	1996-08-29	F. Hoffmann-La Roche Ag	N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
WO1998047500A1 (en)	1997-04-24	1998-10-29	Warner-Lambert Company	Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
US5972986A (en) *	1997-10-14	1999-10-26	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
CA2342981A1 (en) *	1998-09-25	2000-04-06	Warner-Lambert Company	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin

1999
- 1999-07-08 CA CA002342981A patent/CA2342981A1/en not_active Abandoned
- 1999-07-08 DE DE69903458T patent/DE69903458T2/de not_active Expired - Fee Related
- 1999-07-08 US US09/744,130 patent/US6469058B1/en not_active Expired - Fee Related
- 1999-07-08 KR KR1020017003794A patent/KR20010075348A/ko not_active Withdrawn
- 1999-07-08 HK HK02101589.3A patent/HK1040190A1/zh unknown
- 1999-07-08 AT AT99935442T patent/ATE225655T1/de not_active IP Right Cessation
- 1999-07-08 TR TR2001/00859T patent/TR200100859T2/xx unknown
- 1999-07-08 HU HU0103640A patent/HUP0103640A3/hu unknown
- 1999-07-08 PT PT99935442T patent/PT1115391E/pt unknown
- 1999-07-08 CN CN99811320A patent/CN1319009A/zh active Pending
- 1999-07-08 BR BR9913952-9A patent/BR9913952A/pt not_active IP Right Cessation
- 1999-07-08 AU AU50921/99A patent/AU762079B2/en not_active Ceased
- 1999-07-08 ES ES99935442T patent/ES2185378T3/es not_active Expired - Lifetime
- 1999-07-08 NZ NZ510504A patent/NZ510504A/en unknown
- 1999-07-08 EA EA200100369A patent/EA200100369A1/ru unknown
- 1999-07-08 EP EP99935442A patent/EP1115391B1/en not_active Expired - Lifetime
- 1999-07-08 OA OA1200100078A patent/OA11659A/en unknown
- 1999-07-08 WO PCT/US1999/015386 patent/WO2000018393A1/en not_active Ceased
- 1999-07-08 SK SK360-2001A patent/SK3602001A3/sk unknown
- 1999-07-08 GE GEAP19995872A patent/GEP20043199B/en unknown
- 1999-07-08 ID IDW20010901A patent/ID30046A/id unknown
- 1999-07-08 IL IL14195199A patent/IL141951A0/xx unknown
- 1999-07-08 JP JP2000571912A patent/JP2002525320A/ja active Pending
- 1999-07-08 HR HR20010225A patent/HRP20010225B1/xx not_active Application Discontinuation
- 1999-07-08 YU YU22401A patent/YU22401A/sh unknown
- 1999-07-08 PL PL99348673A patent/PL348673A1/xx not_active Application Discontinuation
- 1999-07-08 AP APAP/P/2001/002109A patent/AP2001002109A0/en unknown
- 1999-07-08 EE EEP200100187A patent/EE200100187A/xx unknown
- 1999-07-08 CZ CZ2001905A patent/CZ2001905A3/cs unknown
- 1999-07-08 DK DK99935442T patent/DK1115391T3/da active
2001
- 2001-03-14 IS IS5888A patent/IS5888A/is unknown
- 2001-03-16 ZA ZA200102233A patent/ZA200102233B/en unknown
- 2001-03-23 NO NO20011493A patent/NO20011493L/no not_active Application Discontinuation
- 2001-04-25 BG BG105470A patent/BG105470A/xx unknown
2002
- 2002-10-08 US US10/184,309 patent/US20030170300A1/en not_active Abandoned
- 2002-10-09 US US10/185,221 patent/US20030086965A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU5092199A (en)	2000-04-17
SK3602001A3 (en)	2002-07-02
CZ2001905A3 (cs)	2001-08-15
AU762079B2 (en)	2003-06-19
EP1115391A1 (en)	2001-07-18
ES2185378T3 (es)	2003-04-16
ZA200102233B (en)	2002-06-18
OA11659A (en)	2004-12-08
CA2342981A1 (en)	2000-04-06
NO20011493L (no)	2001-05-23
BR9913952A (pt)	2001-06-12
HUP0103640A3 (en)	2003-01-28
IL141951A0 (en)	2002-03-10
WO2000018393A1 (en)	2000-04-06
HK1040190A1 (zh)	2002-05-31
NZ510504A (en)	2003-09-26
YU22401A (sh)	2004-03-12
DE69903458T2 (de)	2003-07-10
EP1115391B1 (en)	2002-10-09
EA200100369A1 (ru)	2001-10-22
IS5888A (is)	2001-03-14
HRP20010225B1 (en)	2004-10-31
PT1115391E (pt)	2003-02-28
AP2001002109A0 (en)	2001-03-31
TR200100859T2 (tr)	2001-08-21
DE69903458D1 (de)	2002-11-14
ATE225655T1 (de)	2002-10-15
GEP20043199B (en)	2004-03-25
US20030170300A1 (en)	2003-09-11
DK1115391T3 (da)	2003-02-10
HUP0103640A2 (en)	2002-06-29
HRP20010225A2 (en)	2002-04-30
PL348673A1 (en)	2002-06-03
US6469058B1 (en)	2002-10-22
BG105470A (en)	2001-12-29
CN1319009A (zh)	2001-10-24
JP2002525320A (ja)	2002-08-13
US20030086965A1 (en)	2003-05-08
ID30046A (id)	2001-11-01
NO20011493D0 (no)	2001-03-23
KR20010075348A (ko)	2001-08-09

Publication	Publication Date	Title
EE200100187A (et)	2002-08-15	Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga
EE200000577A (et)	2002-04-15	Elektronpääsmete või nendega seotud täiustused
PT1114031E (pt)	2005-09-30	4-carboxiamino-1,2,3,4-tetradhiroquinolinas substituidas em posicao 2
NO20006520D0 (no)	2000-12-20	Adenosinderivater
ATA206798A (de)	1999-12-15	Orthodontischer bauteil, insbesondere bracket mit einem einsatzelement
ID27433A (id)	2001-04-12	Deret transmit pancaran ganda dengan intermodulasi rendah
BR9912040B1 (pt)	2008-11-18	vÁlvula em profundidade, e acabamento de poÇo.
ID30250A (id)	2001-11-15	Kemoterapi kombinasi
ZA992255B (en)	1999-10-05	Antitumor synergetic composition.
ZA200201548B (en)	2004-01-28	Parenteral cisplatin emulsion.
SI1115391T1 (en)	2003-02-28	Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
TR199900635A3 (tr)	1999-10-21	Pozitif kontrollü tüylendirme silindirleri içeren tüylendirme makinesi.
FR2779658B1 (fr)	2000-09-08	Planche de glisse
IT245830Y1 (it)	2002-03-26	Autoveicolo con sedili anteriori girevoli.
IT1305654B1 (it)	2001-05-15	Resistenze corazzate con guaina perfezionata.
ES1039380Y (es)	1999-05-01	Pendiente de cierre delantero.
KR980000233U (ko)	1998-03-30	주머니를 구비한 장갑
DK9800114U3 (da)	1998-09-25	Jalousi-skab med oplukkelig bordarr. med integreret opslagstavle
ES1040517Y (es)	1999-08-16	Sembradora de semillas en bandejas.
ES1041848Y (es)	2000-01-01	Perfil frontal para cerraduras.
ES1041570Y (es)	1999-12-16	Encendedor de bolsillo perfeccionado.
BR8202541Y1 (pt)	2010-11-03	aperfeiçoamento introduzido em bolsão.
IT1304340B1 (it)	2001-03-15	Misuratore antropometrico con scoliosigrafo.
FI3800U1 (fi)	1999-03-01	Tulisijaluukkujärjestely
ES1041869Y (es)	2000-01-01	Perfeccionamientos introducidos en extrusionadoras de cereal.